When Do You Start to See Results from Wegovy?

What happens in the first few weeks on Wegovy?

The question our prescribers hear most weeks is some version of: 'I've had two injections and the scales haven't moved, is something wrong?' The short answer is almost certainly no. Wegovy's early job is adjustment, not transformation. Semaglutide starts reducing appetite signals fairly quickly (many people notice they feel full sooner, or that the pull towards snacking has quietly faded) but the body's fat stores take longer to reflect that change on a scale.

The starting dose of 0.25mg is a tolerability step. It exists so your digestive system can adapt gradually; nausea, the most common early side effect, is usually gentler this way. At that dose, significant weight loss is not the expectation. If you want more detail on how the dose schedule unfolds over the first months, this page on how long Wegovy takes to work covers the titration timeline specifically.

The NHS notes that GI side effects (nausea, loose stools, indigestion) tend to be most noticeable in the first days after a new dose, settling as the weeks pass. Knowing this in advance makes it easier to stay the course during the adjustment window.

When do most people see noticeable weight loss from semaglutide?

For the majority of people on Wegovy, the shift from 'something is happening' to 'I can see this working' tends to land somewhere between weeks six and twelve, and if you are wondering when you should start seeing results from Wegovy, that window is a reasonable benchmark to work from. That is usually around the time the dose steps up to 0.5mg or 1.0mg, and appetite suppression becomes more consistent throughout the day rather than intermittent.

The STEP 1 trial (published in the New England Journal of Medicine and the primary evidence base for Wegovy's licence) enrolled over 1,900 adults without diabetes over 68 weeks. Participants on 2.4mg semaglutide alongside lifestyle changes achieved an average body-weight reduction of around 15%. That figure was reached progressively; the steepest losses came during the months when the dose was climbing toward maintenance, not at the start.

Progress also varies by individual. Factors including starting weight, how strictly dietary changes are followed, activity levels, and how well the medicine is tolerated at each dose step all affect the pace. Some people lose weight faster early on; others find the biggest changes come after month four or five. Neither pattern is a failure. If you are curious about what longer-term milestones tend to look like, this page on longer-term weight loss targets on Wegovy discusses what the evidence says about bigger goals.

Does when you see results depend on which dose you are on?

Yes, quite directly. The licensed maintenance dose for Wegovy injection is 2.4mg weekly (with a 7.2mg option approved by the MHRA in January 2026 for some patients). The titration schedule moves through 0.25mg, 0.5mg, 1.0mg and 1.7mg before reaching 2.4mg, with roughly four weeks at each step. Each increase tends to bring a renewed appetite reduction, which is why many people describe the six-month mark as the point when results feel most substantial, and our guide to when you see results on Wegovy explains how those dose steps connect to the changes people notice.

This has a practical implication: people who compare their week-eight results to a friend's month-six results are comparing different points on the same curve. Trying to skip steps to get results faster isn't how the medicine works, and it increases the risk of side effects. Your prescriber sets the pace based on how you are tolerating each level. For a broader look at what to expect across the full treatment period, our Wegovy overview covers the licensed pathway in more detail.

The same principle applies to the newer oral semaglutide (Wegovy tablets), approved by the MHRA in June 2026 as the UK's first licensed oral GLP-1 medicine for weight management. It follows a different dose schedule to the injection and a separate evidence base, so direct timeline comparisons between the two formats aren't straightforward.

What should you do if results feel slow or have stalled?

Plateaus mid-treatment are expected and do not mean the medicine has stopped working. They are often a signal that the body has adapted to a particular calorie level, and the next dose increase or a dietary adjustment can restart progress. The NHS patient information for semaglutide recommends continuing alongside a reduced-calorie diet and regular physical activity, Wegovy is a medicine that works in partnership with lifestyle changes, not instead of them.

If you are at maintenance dose, have been for several months, and have lost less than 5% of your starting weight, NICE guidance (TA875) suggests reviewing whether continuing makes clinical sense. That is a conversation with your prescriber, not a self-assessment. At nume, every repeat order is clinically re-reviewed; it is never automatic. If the medicine is working but progress has slowed, this page on starting to see weight loss on Wegovy goes into the factors that influence pace in more detail.

If you have not yet started and want to understand what the assessment involves, checking your eligibility with our prescribers is a good first step. There is no obligation, and the consultation is free.